J&J to open innovation centers in US, UK and China

Singapore: Johnson & Johnson plans to establish four regional innovation centers in major life sciences communities ...

September 19, 2012 | Wednesday | News
Amgen progresses on Ph II study of migraine drug

Singapore: Amgen has received positive results from its global Phase 2 clinical trial of AMG 334, a fully human monoclon...

May 18, 2015 | Monday | News
OccuRx kick starts with $5.21 mn investment

Singapore: OccuRx, an Australian biopharmaceutical company developing a new class of drugs to prevent health burden due ...

May 18, 2015 | Monday | News
Nektar's therapy helps the body kill its own cancer

Singapore: US-based Nektar Therapeutics has revealed positive preclinical data for NKTR-214, a novel cancer immunotherap...

April 9, 2013 | Tuesday | News
Researchers discover antibody to prevent dengue

Singapore: A group of international researchers, including from University of Melbourne, have discovered a new class of ...

December 31, 2014 | Wednesday | News
Suven Lifesciences receives five patents from four countries

Singapore: India-based Suven Lifescinces has secured patents for its new chemical entities (NCEs) from Japan, China, New...

December 17, 2014 | Wednesday | News
Israel firm gets US, China patent for neuro-peptide

Singapore: Israel-based D-Pharm has recieved new patent in the US and China, related to composition and use of THR-18, a...

October 31, 2013 | Thursday | News
Brain cancer drug may be effective in melanoma treatment

Singapore: Australia based Novogen's lead candidate, TRXE-009, developed for the treatment of brain cancers, has shown t...

December 17, 2014 | Wednesday | News
Singapore scientists find new clues on cervical cancer

Singapore: A team of scientists from Cancer Science Institute of Singapore (CSI Singapore) at the National University of...

December 9, 2015 | Wednesday | News
Japan gets Certara's D360 to boost drug discovery

Singapore: Certara, a drug development and drug safety consultancy firm has launched its D360 software in Japan for prov...

August 4, 2014 | Monday | News
3SBio to develop antibody for acute leukemia

Singapore: Chinese biotechnology firm, 3SBio, has signed an exclusive license with Korean firm, DiNonA  for the develop...

August 8, 2014 | Friday | News
Aussie firm initiates bronchitis drug trial for smokers

Singapore: Australia-based clinical-stage drug development company, Invion, initiated and commenced patient enrolment in...

July 23, 2013 | Tuesday | News
Breast cancer boasts of highest drug pipeline'

Singapore: Breast cancer therapeutics pipeline has higher innovation in first-in-class molecules, with many new technolo...

September 8, 2014 | Monday | News
Ascend to begin PhII trial for skin cancer

Singapore: Ascend Biopharmaceuticals, a Melbourne-based immunotherapy company, plans to begin a Phase 2 clinical trial o...

September 11, 2014 | Thursday | News
Singapore firm progresses on urinary tract infections drug

Singapore: Singapore's biopharmaceutical company, MerLion Pharmaceuticals, has recieved positive results from a phase 2 ...

January 9, 2015 | Friday | News
US investment firm expands in China

Singapore: Ally Bridge Group (ABG), a global healthcare-focused investment platform, has expanded its global biopharmace...

January 9, 2015 | Friday | News
Aspirin may reduce ovarian cancer risk: NIH

Singapore: Women who take aspirin daily may reduce their risk of ovarian cancer by 20 percent, according to a study by s...

February 7, 2014 | Friday | Analysis
Zebrafish genes linked to human respiratory diseases'

Singapore: A small freshwater fish found in many tropical aquariums may hold the key to unlocking one of the leading cau...

September 22, 2014 | Monday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls